← Back to headlines
Bank of America Upgrades AbbVie, Lifts Price Target
Bank of America has upgraded its rating for pharmaceutical company AbbVie, citing the strong performance of its drug Skyrizi, and subsequently increased its price target for the stock.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
